Analysed FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) News Sources
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
13-05-2026
yahoo.com
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
14-05-2026
yahoo.com
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
18-05-2026
yahoo.com
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
19-05-2026
yahoo.com
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
27-07-2026
yahoo.com
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
05-08-2026
yahoo.com
Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
12-08-2026
yahoo.com
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
13-08-2026
yahoo.com
What is the current price of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)?
The current price of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) is $18.45.
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) absolute price change since previous trading day?
The absolute price change of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) since the previous trading day is $-0.125.
FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) percentage price change since previous trading day?
The percentage price change of FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) since the previous trading day is -0.6729%.
What is the most recent average sentiment score for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)?
The most recent average sentiment score for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)?
The most recent sentiment for FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ) is .
SEC-8K** Filing Available For FORTRESS BIOTECH INC - FBIO 9 3/8 PERP (FBIOP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.